Four-component research blend containing GHK-Cu, BPC-157, TB-500 10mg and KPV, supplied as a lyophilised vial.
KLOW combines four separate research peptides: GHK-Cu, BPC-157, TB-500 and KPV. It is studied in controlled laboratory and preclinical models involving extracellular-matrix signalling, cellular migration, angiogenic responses and inflammatory pathways. The combined blend has not been clinically evaluated. For laboratory research only. Not for human or veterinary use.
The following information is provided for research-catalogue and product specification purposes only. Batch-specific identity, purity, salt form and analytical values should be confirmed against the relevant Certificate of Analysis.
| What it is | KLOW combines four separate research peptides: GHK-Cu, BPC-157, TB-500 and KPV. It is studied in controlled laboratory and preclinical models involving extracellular-matrix signalling, cellular migration, angiogenic responses and inflammatory pathways. The combined blend has not been clinically evaluated. For laboratory research only. Not for human or veterinary use. |
|---|---|
| Sequence | GHK-Cu: Gly-His-Lys·Cu(II) BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser KPV: Lys-Pro-Val |
| Molecular weight | GHK-Cu: 401.91 g/mol; BPC-157: 1419.5 g/mol; TB-500: 4963 g/mol; KPV: 342.43 g/mol |
| Product family | Multi-Peptide Research Blends |
| Research classification | Four-peptide blend / Tissue and extracellular-matrix signalling research |
| Form | Lyophilised four-peptide blend |
| Appearance | Blue to blue-green lyophilised powder |
| Fill quantity | 80mg |
| Container type | Sealed glass vial |
| Storage | Store at 2–8°C for short-term storage or at −20°C for long-term storage. Protect from light and moisture. Avoid repeated freeze-thaw cycles and refer to the batch-specific Certificate of Analysis. |
| Synonyms | KLOW; GHK-Cu/BPC-157/TB-500/KPV blend; GLOW + KPV; four-peptide research blend |
| CAS number | GHK-Cu: 89030-95-5; BPC-157: 137525-51-0; TB-500: 77591-33-4; KPV: 67727-97-3 |
| Molecular form / formula | GHK-Cu: C14H22CuN6O4; BPC-157: C62H98N16O22; TB-500: C212H350N56O78S; KPV: C16H30N4O4 |
| Molecule form | Four-component lyophilised blend; GHK copper(II) complex; counter-ion according to batch COA |
| Purity | ≥99% per component (HPLC; batch-specific COA) |
| Analysis method | HPLC and mass spectrometry (MS) |
Each compound is accompanied by third-party analytical documentation where available. Certificates confirm purity, identity and chromatographic analysis against the supplied batch.
Orders are typically processed within 1–2 business days of confirmed payment. Estimated delivery is 10–21 business days after dispatch, depending on destination and courier coverage. All shipping is tracked and discreetly packaged.
Store at 2–8°C for short-term storage or at −20°C for long-term storage. Protect from light and moisture. Avoid repeated freeze-thaw cycles and refer to the batch-specific Certificate of Analysis.
| Form | Lyophilised four-peptide blend |
|---|---|
| Appearance | Blue to blue-green lyophilised powder |
| Container type | Sealed glass vial |
| Storage & Handling | Store at 2–8°C for short-term storage or at −20°C for long-term storage. Protect from light and moisture. Avoid repeated freeze-thaw cycles and refer to the batch-specific Certificate of Analysis. |
All products are supplied by Greek Peptides for research use only. They are not licensed as pharmaceuticals and are not promoted as, or intended to diagnose, treat, cure, prevent or mitigate any disease or medical condition in humans or animals. They are not intended for human or animal consumption and are not intended for cosmetic, nutritional or recreational use.
By purchasing, the purchaser confirms that they are a qualified individual acting for legitimate research purposes only and accepts our Terms and Conditions and Research Use Policy.
